0 Σχόλια
0 Μοιράστηκε
173 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Precision in Oncology: How Radiation Treatment Planning Software Is Revolutionizing Cancer CareThe fight against cancer requires precision, innovation, and the ability to deliver targeted therapies that maximize efficacy while minimizing harm to healthy tissues. Radiation treatment planning software has emerged as a cornerstone of modern oncology, enabling clinicians to design and execute highly precise brachytherapy treatments tailored to individual patient anatomy. According to...0 Σχόλια 0 Μοιράστηκε 255 Views 0 Προεπισκόπηση
-
Precision Medicine: How Precision Oncology Is Transforming Cancer TreatmentThe Cancer Tumor Profiling Market is experiencing significant growth as precision oncology continues to transform cancer treatment and patient care. According to market reports, the global Cancer Tumor Profiling Market was valued at USD 5.64 billion in 2024 and is projected to reach USD 12.0 billion by 2035, exhibiting a CAGR of 7.1% during the forecast period. This steady growth...0 Σχόλια 0 Μοιράστηκε 153 Views 0 Προεπισκόπηση
-
Epidermal Growth Factor Receptor Inhibitor Market Growth Drivers and Investment OpportunitiesThe global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Global Dual-Antibody ADC Market Growing at 6.2% CAGR Through 2032According to a new report from Intel Market Research, the global Dual-Antibody ADC market was valued at USD 477 million in 2024 and is projected to reach USD 691 million by 2032, exhibiting a steady CAGR of 6.2% during the forecast period (2025–2032). This growth is driven by increasing cancer prevalence and demand for precision medicine, superior tumor targeting capabilities of...0 Σχόλια 0 Μοιράστηκε 625 Views 0 Προεπισκόπηση
-
HDAC Inhibitor Market Segmentation Analysis by Indication and End UserThe global HDAC inhibitor market is gaining significant momentum as the healthcare industry continues to advance targeted therapies for cancer and other complex diseases. Histone deacetylase (HDAC) inhibitors are a class of compounds that regulate gene expression by altering chromatin structure, making them valuable in the treatment of various malignancies and epigenetic disorders. The...0 Σχόλια 0 Μοιράστηκε 982 Views 0 Προεπισκόπηση
-
Precision Cancer Diagnostic Tests Market Advancements Improving Cancer Survival RatesThe global precision cancer diagnostic tests market is witnessing remarkable growth due to the increasing demand for personalized medicine, advancements in molecular diagnostics, and rising cancer prevalence worldwide. Precision cancer diagnostics play a critical role in identifying genetic mutations, biomarkers, and molecular characteristics of tumors, enabling healthcare providers to develop...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...0 Σχόλια 0 Μοιράστηκε 911 Views 0 Προεπισκόπηση
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)